{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T05:46:14Z","timestamp":1791006374431,"version":"4.1.0"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,2]]},"DOI":"10.1093\/brain\/awh046","type":"journal-article","created":{"date-parts":[[2004,1,15]],"date-time":"2004-01-15T17:12:59Z","timestamp":1074186779000},"page":"363-370","source":"Crossref","is-referenced-by-count":135,"title":["Why is parkinsonism not a feature of human methamphetamine users?"],"prefix":"10.1093","volume":"127","author":[{"given":"Anna","family":"Moszczynska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Fitzmaurice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Ang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn S.","family":"Kalasinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory A.","family":"Schmunk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank J.","family":"Peretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally S.","family":"Aiken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis J.","family":"Wickham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Kish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2004,2]]},"reference":[{"key":"key\n\t\t\t\t20170624054833_AWH046C1","doi-asserted-by":"crossref","unstructured":"Adolfsson R, Gottfries CG, Roos BE, Winblad B. Post\u2010mortem distribution of dopamine and homovanillic acid in human brain, variations related to age, and a review of the literature. J Neural Transm1979; 45: 81\u2013105.","DOI":"10.1007\/BF01250085"},{"key":"key\n\t\t\t\t20170624054833_AWH046C2","doi-asserted-by":"crossref","unstructured":"Alexander GE, DeLong MR, Strick PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci1986; 9: 357\u201381.","DOI":"10.1146\/annurev.ne.09.030186.002041"},{"key":"key\n\t\t\t\t20170624054833_AWH046C3","doi-asserted-by":"crossref","unstructured":"Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci1973; 20: 415\u201355.","DOI":"10.1016\/0022-510X(73)90175-5"},{"key":"key\n\t\t\t\t20170624054833_AWH046C4","doi-asserted-by":"crossref","unstructured":"Chang L, Ernst T, Speck O, Patel H, DeSilva M, Leonido\u2010Yee M, et al. Perfusion MRI and computerized cognitive test abnormalities in abstinent methamphetamine users. Psychiatry Res2002; 114: 65\u201379.","DOI":"10.1016\/S0925-4927(02)00004-5"},{"key":"key\n\t\t\t\t20170624054833_AWH046C50","doi-asserted-by":"crossref","unstructured":"De La Fuente\u2010Fern\u00e1ndez R, Furtado S, Guttman M, Furukawa Y, Lee CS, et al. VMAT2 binding is elevated in dopa\u2010responsive dystonia: visualizing empty vesicles by PET. Synapse2003; 49: 20\u201328.","DOI":"10.1002\/syn.10199"},{"key":"key\n\t\t\t\t20170624054833_AWH046C5","doi-asserted-by":"crossref","unstructured":"Fibiger HC, MoGeer EG. Effect of acute and chronic methamphetamine treatment on tyrosine hydroxylase activity in brain and adrenal medulla. Eur J Pharmacol1971; 16: 176\u201380.","DOI":"10.1016\/0014-2999(71)90008-2"},{"key":"key\n\t\t\t\t20170624054833_AWH046C6","doi-asserted-by":"crossref","unstructured":"Frey K, Kilbourn M, Robinson T. Reduced striatal vesicular monoamine transporters after neurotoxic but not after behaviorally\u2010sensitizing doses of methamphetamine. Eur J Pharmacol1997; 334: 273\u20139.","DOI":"10.1016\/S0014-2999(97)01152-7"},{"key":"key\n\t\t\t\t20170624054833_AWH046C7","doi-asserted-by":"crossref","unstructured":"Harvey DC, Lacan G, Melegan WP. Regional heterogeneity of dopaminergic deficits in vervet monkey striatum and substantia nigra after methamphetamine exposure. Exp Brain Res2000a; 133: 349\u201358.","DOI":"10.1007\/s002210000386"},{"key":"key\n\t\t\t\t20170624054833_AWH046C8","doi-asserted-by":"crossref","unstructured":"Harvey DC, Lacan G, Tanious SP, Melega WP. Recovery from methamphetamine induced long\u2010term nigrostriatal dopaminergic deficits without substantia nigra cell loss. Brain Res2000b; 871: 259\u201370.","DOI":"10.1016\/S0006-8993(00)02439-2"},{"key":"key\n\t\t\t\t20170624054833_AWH046C9","unstructured":"Hornykiewicz O, Kish SJ. Biochemical pathophysiology of Parkinson\u2019s disease. Adv Neurol1986; 45: 19\u201334."},{"key":"key\n\t\t\t\t20170624054833_AWH046C10","doi-asserted-by":"crossref","unstructured":"Kalasinsky KS, Bosy TZ, Schmunk GA, Reiber G, Anthony RM, Furukawa Y, et al. Regional distribution of methamphetamine in autopsied brain of chronic human methamphetamine users. Forensic Sci Int2001; 116: 163\u20139.","DOI":"10.1016\/S0379-0738(00)00368-6"},{"key":"key\n\t\t\t\t20170624054833_AWH046C11","doi-asserted-by":"crossref","unstructured":"Kish SJ, Shannak K, Hornykiewicz O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson\u2019s disease. Pathophysiologic and clinical implications. New Engl J Med1988; 318: 876\u201380.","DOI":"10.1056\/NEJM198804073181402"},{"key":"key\n\t\t\t\t20170624054833_AWH046C12","doi-asserted-by":"crossref","unstructured":"Kramer JC, Fischman VS, Littlefield DC. Amphetamine abuse. Pattern and effects of high doses taken intravenously. JAMA1967; 201: 305\u20139.","DOI":"10.1001\/jama.201.5.305"},{"key":"key\n\t\t\t\t20170624054833_AWH046C13","unstructured":"Laruelle M, Abi\u2010Dargham A, van Dyck CH, Rosenblatt W, Zea\u2010Ponce Y, Zoghbi SS, et al. SPECT imaging of striatal dopamine release after amphetamine challenge. J Nucl Med1995; 36: 1182\u201390."},{"key":"key\n\t\t\t\t20170624054833_AWH046C14","doi-asserted-by":"crossref","unstructured":"Linder JC, Young SJ, Groves PM. Electron microscopic evidence for neurotoxicity in the basal ganglia. Neurochem Int1995; 26: 195\u2013202.","DOI":"10.1016\/0197-0186(94)00110-G"},{"key":"key\n\t\t\t\t20170624054833_AWH046C15","doi-asserted-by":"crossref","unstructured":"Lundh H, Tunving K. An extrapyramidal choreiform syndrome caused by amphetamine addiction. J Neurol Neurosurg Psychiatry1981; 44: 728\u201330.","DOI":"10.1136\/jnnp.44.8.728"},{"key":"key\n\t\t\t\t20170624054833_AWH046C16","doi-asserted-by":"crossref","unstructured":"McKetin R, Mattick RP. Attention and memory in illicit amphetamine users. Drug Alcohol Depend1997; 48: 235\u201342.","DOI":"10.1016\/S0376-8716(97)00132-4"},{"key":"key\n\t\t\t\t20170624054833_AWH046C17","doi-asserted-by":"crossref","unstructured":"Paulus MP, Hozack NE, Zauscher BE, Frank L, Brown GG, Braff DL, et al. Behavioral and functional neuroimaging evidence for prefrontal dysfunction in methamphetamine\u2010dependent subjects. Neuropsycho pharmacology2002; 26: 53\u201363.","DOI":"10.1016\/S0893-133X(01)00334-7"},{"key":"key\n\t\t\t\t20170624054833_AWH046C18","doi-asserted-by":"crossref","unstructured":"Ricaurte GA, McCann UD. Neurotoxic amphetamine analogues: effects in monkeys and implications for humans. Ann NY Acad Sci1992; 648: 371\u201382.","DOI":"10.1111\/j.1749-6632.1992.tb24586.x"},{"key":"key\n\t\t\t\t20170624054833_AWH046C19","doi-asserted-by":"crossref","unstructured":"Riddle EL, Topham MK, Haycock JW, Hanson GR, Fleckenstein AE. Differential trafficking of the vesicular monoamine transporter\u20102 by methamphetamine and cocaine. Eur J Pharmacol2002; 449: 71\u20134.","DOI":"10.1016\/S0014-2999(02)01985-4"},{"key":"key\n\t\t\t\t20170624054833_AWH046C20","doi-asserted-by":"crossref","unstructured":"Rogers RD, Everitt BJ, Baldacchino A, Blackshaw AJ, Swainson R, Wynne K, et al. Dissociable deficits in the decision\u2010making cognition of chronic amphetamine abusers, opiate abusers, patients with focal damage to prefrontal cortex, and tryptophan\u2010depleted normal volunteers: evidence for monaminergic mechanisms. Neuropsychopharmacology1999; 20: 322\u201339.","DOI":"10.1016\/S0893-133X(98)00091-8"},{"key":"key\n\t\t\t\t20170624054833_AWH046C21","doi-asserted-by":"crossref","unstructured":"Seiden LS, Fischman MW, Schuster CR. Long\u2010term methamphetamine induced changes in brain catecholamines in tolerant rhesus monkeys. Drug Alcohol Depend1976; 1: 215\u20139.","DOI":"10.1016\/0376-8716(76)90030-2"},{"key":"key\n\t\t\t\t20170624054833_AWH046C22","doi-asserted-by":"crossref","unstructured":"Simon SL, Domier C, Carnell J, Brethen P, Rawson R, Ling W. Cognitive impairment in individuals currently using methamphetamine. Am J Addict2000; 9: 222\u201331.","DOI":"10.1080\/10550490050148053"},{"key":"key\n\t\t\t\t20170624054833_AWH046C23","doi-asserted-by":"crossref","unstructured":"Sonsalla PK, Jochnowitz ND, Zeevalk GD, Oostveen JA, Hall ED. Treatment of mice with methamphetamine produces cell loss in the substantia nigra. Brain Res1996; 738: 172\u20135.","DOI":"10.1016\/0006-8993(96)00995-X"},{"key":"key\n\t\t\t\t20170624054833_AWH046C24","doi-asserted-by":"crossref","unstructured":"Spokes EG. An analysis of factors influencing measurements of dopamine, noradrenaline, glutamate decarboxylase and choline acetylase in human post\u2010mortem brain tissue. Brain1979; 102: 333\u201346.","DOI":"10.1093\/brain\/102.2.333"},{"key":"key\n\t\t\t\t20170624054833_AWH046C25","doi-asserted-by":"crossref","unstructured":"Tong J, Ross BM, Schmunk GA, Peretti FJ, Kalasinsky KS, Furukawa Y, et al. Decreased striatal dopamine D1 receptor\u2010stimulated adenylyl cyclase activity in human methamphetamine users. Am J Psychiatry2003; 160: 896\u2013903.","DOI":"10.1176\/appi.ajp.160.5.896"},{"key":"key\n\t\t\t\t20170624054833_AWH046C26","doi-asserted-by":"crossref","unstructured":"Vander Borght T, Kilbourn M, Desmond T, Kuhl DE, Frey KA. The vesicular monoamine transporter is not regulated by dopaminergic drug treatments. Eur J Pharmacol1995; 294: 577\u201383.","DOI":"10.1016\/0014-2999(95)00594-3"},{"key":"key\n\t\t\t\t20170624054833_AWH046C27","doi-asserted-by":"crossref","unstructured":"Wilson JM, Kish SJ. The vesicular monoamine transporter, in contrast to the dopamine transporter, is not altered by chronic cocaine self\u2010administration in the rat. J Neurosci1996; 16: 3507\u201310.","DOI":"10.1523\/JNEUROSCI.16-10-03507.1996"},{"key":"key\n\t\t\t\t20170624054833_AWH046C28","doi-asserted-by":"crossref","unstructured":"Wilson JM, Nobrega JN, Carroll ME, Niznik HB, Shannak K, Lac ST, et al. Heterogeneous subregional binding patterns of 3H\u2010WIN 35,428 and 3H\u2010GBR 12,935 are differentially regulated by chronic cocaine self\u2010administration. J Neurosci1994; 14: 2966\u201379.","DOI":"10.1523\/JNEUROSCI.14-05-02966.1994"},{"key":"key\n\t\t\t\t20170624054833_AWH046C29","doi-asserted-by":"crossref","unstructured":"Wilson JM, Kalasinsky KS, Levey AI, Bergeron C, Reiber G, Anthony RM, et al. Striatal dopamine nerve terminal markers in human, chronic methamphetamine users. Nat Med1996a; 2: 699\u2013703.","DOI":"10.1038\/nm0696-699"},{"key":"key\n\t\t\t\t20170624054833_AWH046C30","doi-asserted-by":"crossref","unstructured":"Wilson JM, Levey AI, Rajput A, Ang L, Guttman M, Shannak K, et al. Differential changes in neurochemical markers of striatal dopamine nerve terminals in idiopathic Parkinson\u2019s disease. Neurology1996b; 47: 718\u201326.","DOI":"10.1212\/WNL.47.3.718"},{"key":"key\n\t\t\t\t20170624054833_AWH046C31","doi-asserted-by":"crossref","unstructured":"Wise RA. Neurobiology of addiction. Curr Opin Neurobiol1996; 6: 243\u201351.","DOI":"10.1016\/S0959-4388(96)80079-1"},{"key":"key\n\t\t\t\t20170624054833_AWH046C32","doi-asserted-by":"crossref","unstructured":"Woolverton WL, Ricaurte GA, Forno LS, Seiden LS. Long\u2010term effects of chronic methamphetamine administration in rhesus monkeys. Brain Res1989; 486: 73\u20138.","DOI":"10.1016\/0006-8993(89)91279-1"},{"key":"key\n\t\t\t\t20170624054833_AWH046C33","doi-asserted-by":"crossref","unstructured":"Yeterian EH, Pandya DN. Laminar origin of striatal and thalamic projections of the prefrontal cortex in rhesus monkeys. Exp Brain Res1994; 99: 383\u201398.","DOI":"10.1007\/BF00228975"}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/brain\/article-pdf\/127\/2\/363\/17868895\/awh046.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,28]],"date-time":"2020-03-28T23:13:29Z","timestamp":1585437209000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/brain\/article-lookup\/doi\/10.1093\/brain\/awh046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2]]},"references-count":34,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2004,2]]},"published-print":{"date-parts":[[2004,2]]}},"URL":"https:\/\/doi.org\/10.1093\/brain\/awh046","relation":{},"ISSN":["1460-2156","0006-8950"],"issn-type":[{"value":"1460-2156","type":"electronic"},{"value":"0006-8950","type":"print"}],"subject":[],"published":{"date-parts":[[2004,2]]}}}